Nanobiotechnology

Nanobiotechnology


Global Nanobiotechnology Market to Reach US$178.8 Billion by 2030

The global market for Nanobiotechnology estimated at US$111.5 Billion in the year 2023, is expected to reach US$178.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Pharmaceuticals & Biotechnology End-Use Industry, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of the analysis period. Growth in the Medical Devices segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.6 Billion While China is Forecast to Grow at 6.5% CAGR

The Nanobiotechnology market in the U.S. is estimated at US$30.6 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$27.6 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Nanofilms Market - Key Trends & Drivers Summarized

What Are Nanofilms and How Are They Revolutionizing Industries?
Nanofilms are ultra-thin layers of material, often just a few nanometers thick, applied to surfaces to enhance their functionality or performance. These films can be composed of different materials, including metals, ceramics, and polymers, each offering unique properties such as high conductivity, exceptional strength, and resistance to corrosion and wear. Their applications are diverse and span across industries including electronics, healthcare, energy, and automotive. In electronics, for instance, nanofilms are used to improve the efficiency and performance of devices like smartphones and TVs by enhancing screen brightness and color quality. In the healthcare sector, nanofilms contribute to the development of more efficient drug delivery systems and advanced diagnostic tools.

How Are Technological Advancements Influencing Nanofilm Developments?
Technological advancements play a pivotal role in the development of nanofilms, particularly in the methods used for their fabrication and application. Techniques such as atomic layer deposition (ALD), chemical vapor deposition (CVD), and physical vapor deposition (PVD) allow for precise control over the thickness and composition of these films, enabling tailor-made solutions for specific industry needs. Innovations in nanotechnology have also led to the creation of smart nanofilms, which can respond to environmental stimuli such as temperature, light, and pressure. These responsive films are increasingly used in sensors and wearable technology, offering adaptive properties that enhance device functionality and user interaction.

What Market Trends Are Shaping the Future of Nanofilms?
The nanofilm market is being shaped by several significant trends that are influencing both demand and supply dynamics. One of the major trends is the increasing demand for high-performance, miniaturized electronics. As devices become smaller and their functionality increases, the need for advanced materials that can perform at these reduced dimensions grows. Nanofilms meet these requirements by enabling high performance in thin layers, making them ideal for compact electronic devices. Another trend is the growing focus on sustainability, driving interest in nanofilms that contribute to energy efficiency, such as those used in solar panels and energy-efficient windows. Additionally, the automotive industry`s shift towards electric vehicles has increased the need for lightweight, durable materials, where nanofilms are used to enhance battery life and vehicle performance.

What Drives the Growth of the Nanofilm Market?
The growth in the nanofilm market is driven by several factors, including the continued advancement of nanotechnology and material science, which enhances the quality and applicability of nanofilms across various industries. The booming electronics sector, with its constant demand for smaller, faster, and more efficient devices, heavily relies on nanofilm technology to meet these requirements. Additionally, the increasing utilization of nanofilms in the energy sector, particularly in solar energy applications, supports market growth as the world moves towards more renewable energy sources. Consumer behavior also influences this growth, especially as more consumers demand high-performance, durable, and energy-efficient products. Moreover, regulatory trends promoting environmental sustainability encourage the adoption of innovative materials like nanofilms to help reduce environmental impact. These factors collectively drive the dynamic expansion of the nanofilm market, reflecting its integral role in modern technological applications.

Select Competitors (Total 79 Featured) -
  • Ablynx NV
  • Arrowhead Pharmaceuticals Inc.
  • CaPtivate Pharmaceuticals LLC
  • Celgene Corporation
  • ELITechGroup
  • Flamel Technologies SA
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • NanoBio® Corporation
  • Nanophase Technologies Corporation
  • pSivida Corp.
  • Sigma-Aldrich Corp.
  • Starpharma Holdings Ltd.
  • Vectura Group plc
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Nanobiotechnology - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Advances in Nanotechnology Propel Growth in Nanobiotechnology Market
Increasing Demand for Targeted Drug Delivery Expands Addressable Market Opportunity
Growth in Diagnostic and Imaging Applications Generates Demand for Nanobiotechnology Solutions
Technological Innovations in Nanomedicine Strengthen Business Case for Nanobiotechnology
Integration of Nanomaterials in Regenerative Medicine Spurs Growth in Healthcare Sector
Demand for Precision Medicine Expands the Market for Nanobiotechnology
Advances in Nano-Scale Imaging and Sensing Technologies Generate Demand for Innovative Solutions
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Nanobiotechnology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Pharmaceuticals & Biotechnology Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 11: USA Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 12: USA Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: USA 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
CANADA
TABLE 14: Canada Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 15: Canada Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: Canada 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
JAPAN
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 17: Japan Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 18: Japan Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: Japan 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
CHINA
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 20: China Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 21: China Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: China 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
EUROPE
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 23: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: Europe Historic Review for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: Europe 16-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 26: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: Europe 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
FRANCE
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 29: France Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: France Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: France 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
GERMANY
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 32: Germany Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Germany Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Germany 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
ITALY
TABLE 35: Italy Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Italy Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Italy 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
UNITED KINGDOM
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 38: UK Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: UK Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: UK 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Rest of Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Rest of Europe 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Asia-Pacific Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Asia-Pacific 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 47: Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Rest of World Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Rest of World 16-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings